Biocon Ltd.’s consolidated web revenue fell 84.3% within the second quarter of fiscal 2025, lacking analysts’ estimates.
The drugmaker’s revenue declined to Rs 27.1 crore within the September quarter, as in comparison with Rs 172.7 crore within the year-ago interval, in response to an trade submitting on Wednesday. That compares with the Rs 24-crore consensus estimate of analysts tracked by Bloomberg.
The Israel government and Ramat Gan Municipality have reached an agreement in which the Ramat Gan Safari Park will...
Founder Suresh Bansal described it as a strategic milestone toward a sustainability-first global packaging ecosystem. DCGpac plans to expand its smart...
We came across a bullish thesis on Nu Holdings Ltd. on Global Equity Briefing’s Substack by Ray Myers. In this article,...
New York-listed shares of Infosys Ltd. surged over 8% on Wednesday after India's second largest IT firm announced its third...
The combined market valuation of seven of the top-10 most valued firms eroded by Rs 3,63,412.18 crore last week, with...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
